Epilepsy is a complex neurological disorder affecting 70 million people worldwide. One of the major issues regarding epilepsy management is resistance to treatment. Coupling the mechanisms of drugs action with the individual pathogenetic mechanisms of epilepsy represents the best strategy for personalized and effective medication. To this regard, genome-wide analysis and extensive database can be utilized to characterize the etiopathogenic mechanisms underlying epilepsy in individual patients and identify the most effective drugs. In the present paper, we present a systems biology approach to interpret the role of Copy Number Variations (CNVs) in a 27-years old male affected by refractory-epilepsy associated with intellectual disability. In addition to identify causative genotype-phenotype correlations, the synergistic integration of genomic data allowed to decipher the chromosomal aberrations that may underly the pharmaco resistant phenotype. Given the high multifactoriality of drug resistance in epilepsy, the systems biology approach used here could represent a valid tool for its pharmacological management.

A systems biology approach to interpret the pharmacogenomic role of copy number variations in a patient with refractory epilepsy and intellectual disability

Maria Guarnaccia;Sebastiano Cavallaro
2020

Abstract

Epilepsy is a complex neurological disorder affecting 70 million people worldwide. One of the major issues regarding epilepsy management is resistance to treatment. Coupling the mechanisms of drugs action with the individual pathogenetic mechanisms of epilepsy represents the best strategy for personalized and effective medication. To this regard, genome-wide analysis and extensive database can be utilized to characterize the etiopathogenic mechanisms underlying epilepsy in individual patients and identify the most effective drugs. In the present paper, we present a systems biology approach to interpret the role of Copy Number Variations (CNVs) in a 27-years old male affected by refractory-epilepsy associated with intellectual disability. In addition to identify causative genotype-phenotype correlations, the synergistic integration of genomic data allowed to decipher the chromosomal aberrations that may underly the pharmaco resistant phenotype. Given the high multifactoriality of drug resistance in epilepsy, the systems biology approach used here could represent a valid tool for its pharmacological management.
2020
Istituto per la Ricerca e l'Innovazione Biomedica -IRIB
drug resistance epilepsy
systems biology
intellectual disability
personalized medicine
pharmacogenomics
File in questo prodotto:
File Dimensione Formato  
prod_421582-doc_169081.pdf

solo utenti autorizzati

Descrizione: A systems biology approach to interpret the pharmacogenomic role of copy number variations in a patient with refractory epilepsy
Tipologia: Versione Editoriale (PDF)
Dimensione 669.09 kB
Formato Adobe PDF
669.09 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/405998
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact